External
Repatriation Medical Authority Statement

Peripheral neuropathy - Treatment with a drug from list 2 Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]

Preliminary questions [32944]

32945

there is some evidence that being treated with a drug from Specified List 2 may be a factor in the development of the condition under consideration.

32946 the veteran was being treated with a drug from Specified List 2 for treatment of an illness or injury which is identifiable.

32947

for the identified illness or injury, the veteran was being treated with a drug from Specified List 2 at the time of the clinical onset of the condition under consideration.

32948the veteran has established the causal connection between being treated with a drug from Specified List 2 and VEA service for the clinical onset of peripheral neuropathy.

32949the veteran has established the causal connection between being treated with a drug from Specified List 2 and operational service for the clinical onset of peripheral neuropathy.

or

32950the veteran has established the causal connection between being treated with a drug from Specified List 2 and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32949]

32951the identified illness or injury, for which the veteran was being treated with a drug from Specified List 2, is causally related to operational service.

Clinical onset and eligible service [32950]

35736

the identified illness or injury was treated with a drug from Specified List 2 which is available for eligible service cases.

32952the identified illness or injury, for which the veteran was being treated with a drug from Specified List 2, is causally related to eligible service.